572 related articles for article (PubMed ID: 26905920)
21. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
Taylor DM; Young C; Paton C
J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
[TBL] [Abstract][Full Text] [Related]
22. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
23. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.
Howes OD; Vergunst F; Gee S; McGuire P; Kapur S; Taylor D
Br J Psychiatry; 2012 Dec; 201(6):481-5. PubMed ID: 22955007
[TBL] [Abstract][Full Text] [Related]
24. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
25. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
26. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
27. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
Lin CH; Huang CJ; Lin TC; Chan HY; Chen JJ
Psychiatry Res; 2023 Dec; 330():115575. PubMed ID: 37913621
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland.
Jaracz J; Tetera-Rudnicka E; Kujath D; Raczyńska A; Stoszek S; Czernaś W; Wierzbiński P; Moniakowski A; Jaracz K; Rybakowski J
Pharmacol Rep; 2014 Aug; 66(4):613-7. PubMed ID: 24948062
[TBL] [Abstract][Full Text] [Related]
29. Psychotropic drug and polypharmacy use among adolescents and young adults: findings from the Finnish 1981 Nationwide Birth Cohort Study.
Gyllenberg D; Sourander A
Nord J Psychiatry; 2012 Oct; 66(5):336-42. PubMed ID: 22212103
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
31. Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.
Hulkko AP; Murray GK; Moilanen J; Haapea M; Rannikko I; Jones PB; Barnett JH; Huhtaniska S; Isohanni MK; Koponen H; Jääskeläinen E; Miettunen J
Eur Psychiatry; 2017 Sep; 45():50-58. PubMed ID: 28728095
[TBL] [Abstract][Full Text] [Related]
32. Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
Nord J Psychiatry; 2016 Aug; 70(6):450-5. PubMed ID: 27049594
[TBL] [Abstract][Full Text] [Related]
33. Effect of clozapine on polypharmacy.
Chong SA; Remington GJ; Bezchlibnyk-Butler KZ
Psychiatr Serv; 2000 Feb; 51(2):250-2. PubMed ID: 10655014
[TBL] [Abstract][Full Text] [Related]
34. Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.
Tang Y; Horvitz-Lennon M; Gellad WF; Lave JR; Chang CH; Normand SL; Donohue JM
Psychiatr Serv; 2017 Jun; 68(6):579-586. PubMed ID: 28196460
[TBL] [Abstract][Full Text] [Related]
35. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
[TBL] [Abstract][Full Text] [Related]
36. Description of long-term polypharmacy among schizophrenia outpatients.
Suokas JT; Suvisaari JM; Haukka J; Korhonen P; Tiihonen J
Soc Psychiatry Psychiatr Epidemiol; 2013 Apr; 48(4):631-8. PubMed ID: 23007295
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
[TBL] [Abstract][Full Text] [Related]
38. Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation.
Lagreula J; de Timary P; Elens L; Dalleur O
Ther Adv Psychopharmacol; 2022; 12():20451253221112587. PubMed ID: 36051501
[TBL] [Abstract][Full Text] [Related]
39. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
[TBL] [Abstract][Full Text] [Related]
40. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.
Rhee TG; Rosenheck RA
J Affect Disord; 2019 Jun; 252():450-457. PubMed ID: 31004825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]